The US Food and Drug Administration (FDA) has approved the first vaccine for respiratory syncytial virus (RSV) in the United States, the agency announced May 3. Arexvy, manufactured by GSK, is the world's first RSVvaccine for adults aged 60 years and older, the company said in an ...
2https://www.investors.com/news/technology/gsk-stock-jumps-after-beating-pfizer-moderna-to-the-rsv-vaccine-finish-line/ 3https://us.gsk.com/en-us/media/press-releases/us-fda-approves-gsk-s-arexvy-the-world-s-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults/ 4https://www.u...
【1】https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine 【2】 https://www.cnn.com/2023/05/03/health/first-rsv-vaccine-approved/index.html 【3】 https://www.nejm.o...
GSK's jab caps off a decades-long quest.#Green light from US regulatory agency for GSK's jab caps off a decades-long quest.#Respiratory syncytial virus - viral vaccine under research#Respiratory syncytial virus - viral vaccine under research#Respiratory syncytial virus - viral vaccine under ...
FDA approves RSV vaccine The vaccine is approved for at-risk adults in their fifties, making it the first shot approved for the age group. June 8, 2024 Additional Live Streams Additional Live Streams Live ABC News Live Live Authorities investigate deadly New Year celebration terror attack in New...
参考资料：[1]FDA,FDA Approves First COVID-19 Vaccine,FDA Approves First COVID-19 Vaccine ...
3.https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-first-rsv-vaccine-gsk-2023-05-03/ 免责声明:本文旨在传递生物医药最新讯息,不代表平台立场,不构成任何投资意见和建议,以官方/公司公告为准。本文也不是治疗方案推荐,如需获得治疗方案指导,请前往正规医院就诊。
FDA生物制品评价和研究中心(CBER)主任Peter Marks博士表示:“老年人容易患上由RSV引起的严重疾病,尤其是那些有基础健康状况(心脏或肺部疾病或免疫系统减弱)的群体。今天批准的首个RSV疫苗是预防可能致命疾病的重要公共卫生成就。” 参考资料: [1] FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine. Retriev...
The FDA has OK'd FluMist, a nasal spray flu vaccine that you can give and get at home – no health care provider needed. It’s the first flu vaccine of its kind, offering a simple, convenient, needle-free option that its maker hopes will improve access a
特别是那些有慢性阻塞性肺病、哮喘或充血性心力衰竭等潜在健康状况的人，将有可用的疫苗来帮助防止RSV可能带来的严重后果。”参考资料：https://www.gsk.com/en-gb/media/press-releases/us-fda-approves-gsk-s-arexvy-the-world-s-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults/ ...